MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Heatmap
  • Русский
  • 中文
  • Español
  • Português
  • 日本語
  • Deutsch
  • 한국어
  • Français
  • Italiano
  • Türkçe
Clearmind Medicine Inc. Common Shares

CMND

#5255
Clearmind Medicine Inc. Common Shares
0.91 USD
-36.36%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
0.91
0.91
Year Range
0.07
3.25
Daily Change
-36.36%
Monthly Change
+18.18%
6 month change
-3.19%
Year Change
-2.15%
Previous Close
1.43
Open
0.91
Bid
Ask
Low
0.91
High
0.91
Volume
4
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. CMND
Open full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 143.85 K
  • Employee 2
  • Founded 2017
  • CEO N/A
  • Website www.clearmindmedicine.com
  • Headquarter Canada (Federal Level)
  • FIGI BBG01237P3C8
  • Industry Technology
Total revenue
Net income
Total debt
Free cash flow
Cash & equivalents
143.85 K Market capitalization

News

Investing Investing
500
NVDA AMZN NKE CVX
yesterday, 20:30
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.66%
Investing Investing
CMND
2026.03.17
Clearmind Medicine secures six patents in Hong Kong
Investing Investing
CMND
2026.03.13
Clearmind files Hong Kong patent for depression treatment combo
Investing Investing
CMND
2026.03.11
Clearmind advances enrollment in alcohol disorder drug trial
Investing Investing
CMND
2026.03.10
Clearmind files patent for obesity, liver disease treatment combo
Investing Investing
CMND
2026.03.04
Clearmind gets safety board approval to continue AUD trial
Investing Investing
CMND
2026.02.09
Clearmind Medicine stock falls after Phase I/IIa trial safety update
Investing Investing
CMND
2026.02.09
Clearmind reports positive safety results in AUD drug trial
Investing Investing
CMND
2026.02.09
Clearmind reports positive safety data from AUD treatment trial
Investing Investing
CMND
2026.02.06
Clearmind Medicine stock surges after Polyrizon intranasal delivery deal
Investing Investing
CMND
2026.02.06
Clearmind partners with Polyrizon to develop intranasal MEAI formulation
Investing Investing
CMND
2026.02.06
Polyrizon to develop intranasal formulation of Clearmind’s MEAI drug

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
Scan to install from App Store
Scan to install from Google Play
Scan to install from Huawei AppGallery
Scan to install APK
MQL5 Channels
Scan to install from App Store
Scan to install from Google Play
Scan to install from Huawei AppGallery
Scan to install APK
Economic Calendar
Scan to install from App Store
Scan to install from Google Play
Scan to install from Huawei AppGallery
Scan to install APK
Risk Disclosure Terms of Use Help Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd